Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

4,5-Disubstituted 6-Aryloxy-1,3-dihydrobenzo[c][1,2]oxaboroles Are Broad-Spectrum Serine β-Lactamase Inhibitors

12 Jun 2015

Abstract excerpt

Bacterially expressed β-lactamases are rapidly eroding the clinical utility of the important β-lactam class of antibacterials, significantly impairing our ability to fight serious bacterial infections. This paper describes a study of oxaborole-derived β-lactamase inhibitors in which crystal structures and computational modeling aided in the rational design of analogues with improved spectrum of activity against...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antimicrobial Resistance in Staphylococcus
Share to Cancer therapeutics and mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27622821
DOI: 10.1021/acsinfecdis.5b00031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

4,5-Disubstituted 6-Aryloxy-1,3-dihydrobenzo[c][1,2]oxaboroles Are Broad-Spectrum Serine β-Lactamase InhibitorsPMID 27622821Read ↗

Recent advances in the development of β-lactamase inhibitorsSemantic proximity Read ↗

QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological CharacteristicsSemantic proximity Read ↗

β-Lactamases and β-Lactamase Inhibitors in the 21st CenturySemantic proximity Read ↗

Structural Investigations of the Inhibition of Escherichia coli AmpC β-Lactamase by DiazabicyclooctanesSemantic proximity Read ↗

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance.Semantic proximity Read ↗

Discovery of ANT3310 , a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumanniiSemantic proximity Read ↗

Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemasesSemantic proximity Read ↗

Computer-Aided Discovery of a β-Lactam-Independent Deep-Pocket PBP2a Binding Scaffold for Combating MRSA via Pharmacophore-Guided Scaffold Hopping and Bioisosteric ReplacementSemantic proximity Read ↗

A Synthetic Antibiotic Scaffold Effective Against Multidrug-Resistant Bacterial PathogensSemantic proximity Read ↗

New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic DevelopmentSemantic proximity Read ↗

Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamasesSemantic proximity Read ↗

IID572: A New Potentially Best-In-Class β-Lactamase InhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.